Inventor

SCHMIDT BEATE

DE29 patents

⚠️ This page may combine multiple inventors who share the name “SCHMIDT BEATE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHMIDT BEATE

NYCOMED GMBH

2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors

3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors

2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors

Phthalazinone-piperidino-derivatives as PDE4 inhibitors

Triazolophthalazines

Triazolophthalazines

Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation

Roflumilast for the treatment of diabetes mellitus

ALTANA PHARMA AG

Phthalazinone-piperidino-derivatives as PDE4 inhibitors

(Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors

6-heteroarylphenanthridines

Phthalazinone-piperidino-derivatives as PDE4 inhibitors

Piperazino-derivatives and their use as PDE4 inhibitor

Nitrate esters of phenylaminothiophenacetic acid derivatives

Phenanthridine-N-oxides

SCHMIDT BEATE

Triazolophthalazines

Process for preparing crystalline ciclesonide with defined particle size

Pyrazolone derivatives as PDE4 inhibitors

Pyrazolone derivatives as PDE4 inhibitors

STADLWIESER JOSEF

Methylpyrrolopyrimidinecarboxamides

Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines

Methylpyrrolopyridinecarboxamides

TAKEDA GMBH

Pyrazolone-derivatives and their use as PDE-4 inhibitors

Methylpyrrolopyrimidinecarboxamides

Pyrazolone derivatives as PDE4 inhibitors

SCHLEMMINGER IMRE

Pyrazolone-derivatives and their use as PDE-4 inhibitors

KAUTZ ULRICH

3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors

KLEY HANS-PETER

Roflumilast for the treatment of diabetes mellitus type 2

STENGEL THOMAS

Thiophene-imidazopyridines